Audits and cohort studies on the adverse events of bee venom therapy

AE: adverse event; SR: systemic reaction; LR: local reaction; LLR: large local reaction; VIT: venom immunotherapy; RVIT: rush VIT; SIT: specific immunotherapy; RSIT: rush-specific immunotherapy; CVIT; cluster VIT; IP: induction phase; EP: extension phase; MP: maintenance phase.
a If it was not reported in prospective articles, it was considered a retrospective study.
b Venom type: bees (family Apidae); wasps (family Vespidae); single (some bee venom or some wasp venom); mix (bee and wasp venom).
c Incidence: number of patients with AEs/number of patients of total cases, %
d Incidence: number of cases with AEs/number of patients of total cases.
e Incidence: number of injections (dose) that resulted in AEs/total number of injections (dose), % (if the number of patients with AEs was not mentioned or precisely presented).
f Incidence of AEs caused by BVTs combined with the incidence of AEs from other allergens.
g This study was the only report of anaphylaxis related to BVT.
.